Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Dementia and Geriatric Cognitive Disorders
|
February 5, 2003
Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease
M Lindau, V Jelic, S-E Johansson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 29, 2005
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease
E Stefanova, A Wall, O Almkvist, et al.
Journal of Cognitive Neuroscience
|
August 23, 2013
Brain activation in young and older adults during implicit and explicit retrieval
L Bäckman, O Almkvist, J Andersson, et al.
Magnetic Resonance Imaging
|
January 1, 1994
White matter hyperintensities in dementia: does it matter?
L O Wahlund, H Basun, O Almkvist, et al.
Neuroreport
|
March 30, 2001
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment
E Arnáiz, V Jelic, O Almkvist, et al.
Alzheimer Disease and Associated Disorders
|
April 16, 1998
Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation
P Julin, O Almkvist, H Basun, et al.
Archives of Neurology
|
May 1, 1997
Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation
O Almkvist, H Basun, S L Wagner, et al.
Dementia and Geriatric Cognitive Disorders
|
December 23, 2000
White matter lesions impair initiation of FAS flow
S E Fernaeus, O Almkvist, L Bronge, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section
|
January 1, 1990
Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects
H Basun, L G Forssell, O Almkvist, et al.
Acta Endocrinologica
|
August 1, 1990
Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency
M Degerblad, O Almkvist, R Grunditz, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Dementia and Geriatric Cognitive Disorders
|
February 5, 2003
Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease
M Lindau, V Jelic, S-E Johansson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 29, 2005
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease
E Stefanova, A Wall, O Almkvist, et al.
Journal of Cognitive Neuroscience
|
August 23, 2013
Brain activation in young and older adults during implicit and explicit retrieval
L Bäckman, O Almkvist, J Andersson, et al.
Magnetic Resonance Imaging
|
January 1, 1994
White matter hyperintensities in dementia: does it matter?
L O Wahlund, H Basun, O Almkvist, et al.
Neuroreport
|
March 30, 2001
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment
E Arnáiz, V Jelic, O Almkvist, et al.
Alzheimer Disease and Associated Disorders
|
April 16, 1998
Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation
P Julin, O Almkvist, H Basun, et al.
Archives of Neurology
|
May 1, 1997
Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation
O Almkvist, H Basun, S L Wagner, et al.
Dementia and Geriatric Cognitive Disorders
|
December 23, 2000
White matter lesions impair initiation of FAS flow
S E Fernaeus, O Almkvist, L Bronge, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section
|
January 1, 1990
Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects
H Basun, L G Forssell, O Almkvist, et al.
Acta Endocrinologica
|
August 1, 1990
Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency
M Degerblad, O Almkvist, R Grunditz, et al.
Page
of 9